Sharon Benzeno

Sharon Benzeno (senior executive) discloses dealings in Adaptive Biotechnologies Corp to SEC (Form 4). The record holds 15 filings, for trades running from 4 March 2022 to 29 June 2026.

The open-market record consists of 3 sales worth €716k, with no purchase. The totals exclude 2 filings filed without an amount. The rest of the record consists of 5 share grants and 7 option exercises. Since January 2026: no purchases and 3 sales on the market.

The newest entry dates from 30 June 2026: an option exercise, in Adaptive Biotechnologies Corp. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.